Carisma Therapeutics (CARM) Q2 2025 Earnings

13MayConfirmed
Q2 2024
Q3 2024
Q4 2024
Q2 2025
-0.46
-0.34
-0.22
-0.1

Details

Expected EPS
-0.1
Actual EPS
-0.22
Surprise EPS
-0.12
Surprise Percent
+120%

Description

Carisma Therapeutics (CARM) has reported earnings of -0.22 per share for Q2 2025.

0 Comments

Share your thoughts